Medicinova Inc. buy melinda
Start price
15.10.17
/
50%
€6.09
Target price
26.10.17
€6.31
Performance (%)
7.41%
End price
26.10.17
€6.54
Summary
This prediction ended on 26.10.17 with a price of €6.54. With a performance of 7.41%, the BUY prediction by melinda for Medicinova Inc. closed with a slight gain. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Medicinova Inc. | - | - | - | - |
| iShares Core DAX® | 0,44 % | 5,90 % | 8,05 % | 65,58 % |
| iShares Nasdaq 100 | 1,06 % | 0,92 % | 28,47 % | 90,18 % |
| iShares Nikkei 225® | 1,77 % | 1,23 % | 47,57 % | 84,99 % |
| iShares S&P 500 | 0,37 % | 1,92 % | 23,20 % | 70,76 % |
Comments by melinda for this prediction
In the thread Medicinova Inc. diskutieren
Progredienter Multipler Sklerose (progressive MS)
Die erste Zeile der Daten aus dem Phase - 2b wird 28. Oktober präsentiert wird 2017 auf der gemeinsamen Sitzung ECTRIMS - ACTRIMS.